ATP7A and Parkinson disease: Conversely, only two subjects with ILBD (25%), four subjects with PD (40%) and five with DLB (42%) were MC1 positive, whereas 88% of subjects with AD and high neuropathologic changes showed MC1 positive deposits (p = 0.0162, Fig. 3i, summarized in Table 3 and listed in Additional file 1: Table S4).